Advertisement

Latest News

Anaphylaxis Reporting Varies Across Respiratory Biologics In FAERS

55 minutes ago

At ACAAI 2026, Jennifer Priessnitz, MD presented data which found omalizumab had the highest anaphylaxis reporting proportion among 7 respiratory biologics.

Alcohol-Associated Hepatitis Grows as a Liver Transplant Indication

1 hour ago

UNOS data on 82,014 candidates show ALD accounted for 39.0% of steatotic liver disease transplant listings from 2014 to 2024.

ALD Leads Steatotic Liver Disease Transplant Listings, With Leandro Sierra, MD

1 hour ago

UNOS data on 82,014 candidates show ALD accounted for 39.0% of steatotic liver disease transplant listings from 2014 to 2024.

Lessons From ZEUS on Targeting Inflammation, With Peter Libby, MD

4 hours ago

Peter Libby, MD, discusses the neutral ZEUS trial and how coronary inflammation imaging could guide anti-inflammatory therapy in atherosclerosis.

Stepwise Chronic Spontaneous Urticaria Management, With Timothy Craig, DO

4 hours ago

Timothy Craig, DO, outlines stepwise CSU care, from antihistamine updosing to omalizumab, dupilumab, and the oral BTK inhibitor remibrutinib.

Advertisement
Advertisement